Skip to content

Study · Non-randomized trial · 1999

5 results

[The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis].

Medus AI, Pisarevskaia LI, Nikishina EV

Voenno-meditsinskii zhurnal1 Oct 1999

PMID10605346 (opens in a new tab)PepBankPUB-10605346
Publisher pageAsk about this study
Jump to 5 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. 5 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with destructive pulmonary tuberculosis, thymogen stimulated the T-cell immune system.

    In plain wordsIn patients with destructive pulmonary tuberculosis, thymogen stimulated T-cell immune activity.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreaseT-cell immune activity
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The article shows that the immunocorrector timoguen stimulates T-cell link in patients with destructive forms of pulmonary tuberculosis, increases tolerance for ethiotropics, makes intoxication syndromes disappear and heals decomposition cavities and stops the bacteria discharge.
  2. 02HumanNon-randomized trialSafety outcome

    In patients with destructive pulmonary tuberculosis, thymogen increased tolerance of etiotropic drugs.

    In plain wordsIn patients with destructive pulmonary tuberculosis, thymogen increased tolerance of drugs directed at the disease cause.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreaseTolerance of etiotropic treatment
    Study

    n: not reported in source

    Outcome group
    Adverse events · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The article shows that the immunocorrector timoguen stimulates T-cell link in patients with destructive forms of pulmonary tuberculosis, increases tolerance for ethiotropics, makes intoxication syndromes disappear and heals decomposition cavities and stops the bacteria discharge.
  3. 03HumanNon-randomized trialEfficacy outcome

    In patients with destructive pulmonary tuberculosis, thymogen was associated with disappearance of intoxication syndromes.

    In plain wordsIn patients with destructive pulmonary tuberculosis, thymogen treatment was linked to disappearance of intoxication syndromes.

    Peptide
    Thymogen (oglufanide)
    Outcome
    DecreaseIntoxication syndromes
    Study

    n: not reported in source

    Outcome group
    Overall treatment effect · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The article shows that the immunocorrector timoguen stimulates T-cell link in patients with destructive forms of pulmonary tuberculosis, increases tolerance for ethiotropics, makes intoxication syndromes disappear and heals decomposition cavities and stops the bacteria discharge.
  4. 04HumanNon-randomized trialEfficacy outcome

    In patients with destructive pulmonary tuberculosis, thymogen was associated with healing of decomposition cavities.

    In plain wordsIn patients with destructive pulmonary tuberculosis, thymogen treatment was linked to healing of lung cavities.

    Peptide
    Thymogen (oglufanide)
    Outcome
    IncreaseDecomposition cavity healing
    Study

    n: not reported in source

    Outcome group
    Wound healing · Respiratory
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The article shows that the immunocorrector timoguen stimulates T-cell link in patients with destructive forms of pulmonary tuberculosis, increases tolerance for ethiotropics, makes intoxication syndromes disappear and heals decomposition cavities and stops the bacteria discharge.
  5. 05HumanNon-randomized trialEfficacy outcome

    In patients with destructive pulmonary tuberculosis, thymogen was associated with cessation of bacterial discharge.

    In plain wordsIn patients with destructive pulmonary tuberculosis, thymogen treatment was linked to cessation of bacterial discharge.

    Peptide
    Thymogen (oglufanide)
    Outcome
    DecreaseBacterial discharge
    Study

    n: not reported in source

    Outcome group
    Infection and antimicrobial activity · Infection
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The article shows that the immunocorrector timoguen stimulates T-cell link in patients with destructive forms of pulmonary tuberculosis, increases tolerance for ethiotropics, makes intoxication syndromes disappear and heals decomposition cavities and stops the bacteria discharge.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.